Fat and collagen loss drive the hollow look, specialists say, and early research hints GLP-1s may act on skin cells directly. Fillers and lasers are among the options.
Recap by typeshit. Full story at Yahoo Health.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Dr. Nisha Patel and Dr. Gillian Goddard walk through nine reasons, starting with dose. Even in STEP 1, nearly 14% on semaglutide lost under 5% of their weight.
Nestlé is building nutrition products for GLP-1 users, and Circana says alcohol volumes are falling while high-protein, smaller-pack foods gain.
Loading…